Ethyl 6,7-Difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate is a chemical compound used in pharmaceutical research and drug development. It serves as a key building block in the synthesis of active pharmaceutical ingredients, playing a crucial role in the creation of new therapeutic agents. This compound is widely utilized in laboratory settings for its ability to participate in various chemical reactions, making it an essential component in the development of compounds with anti-inflammatory or antimicrobial properties. Its structural complexity allows it to be a versatile reagent in the synthesis of a wide range of pharmaceutical intermediates.
The compound is preferred due to its high chemical stability and reactivity, which make it suitable for a variety of synthetic processes. It exhibits good solubility in organic solvents, facilitating efficient synthesis and purification steps. These properties contribute to its effectiveness in laboratory applications, particularly in research involving the development of new drugs. Additionally, its relatively low toxicity ensures safe handling under controlled laboratory conditions, making it a reliable choice for researchers.
In Indonesian laboratories, this compound is commonly used in drug discovery and pharmaceutical development projects. It is an important tool for scientists working on the synthesis of active pharmaceutical ingredients, supporting both academic and industrial research. Its availability through AMI Scientific ensures that researchers have access to high-quality reagents necessary for their work.
- Used in pharmaceutical development for synthesizing active pharmaceutical ingredients due to its chemical reactivity and structural versatility.
- Applied in anti-inflammatory drug research as a building block for compounds with targeted biological activity.
- Utilized in antimicrobial compound development for its role in creating molecules with broad-spectrum activity.
- Employed in drug discovery projects to generate intermediates for further chemical modification and optimization.
- Integrated into research programs focused on the synthesis of novel therapeutic agents with improved pharmacological profiles.
| Brand | TCI |
|---|---|
| CAS number | 121873-01-6 |
| Molecular formula | — |
| Purity | — |
| Category | Chemistry > Pharmaceutical Development and Drug Discovery Research Reagents > Building Blocks for Pharmaceutical Ingredients |
| Pack sizes | Available in standard laboratory quantities as per supplier specifications |
| Physical form | Solid or liquid, depending on formulation and supplier packaging |
| Storage | — |
This compound should be stored in a cool, dry, and well-ventilated area away from direct sunlight and sources of heat. It is recommended to use airtight containers to prevent moisture absorption and maintain chemical stability. Due to its reactivity, it should be handled with appropriate personal protective equipment, including gloves and safety goggles. In laboratory settings, it should be stored separately from incompatible substances to avoid any potential chemical interactions. Proper labeling and storage conditions ensure the compound remains effective and safe for use in research applications.
—

